HFNO superior to NIV, COT in acute respiratory failure management
High-flow nasal oxygen (HFNO), compared with noninvasive ventilation (NIV), appears to improve clinical outcomes in patients with acute respiratory failure (ARF), results of a study have shown. In postextubation management, HFNO reduces reintubations and leads to patient comfort relative to conventional oxygen therapy (COT). Moreover, it results in fewer harms than NIV or COT.
